Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
RVAC Medicines Announces Research Collaboration with University of Pennsylvania
RVAC Medicines, a messenger RNA (mRNA) technology company with its global headquarters in Singapore, has […]
Hackensack Meridian Health Invests $14 Million Into Oncology Expansion at JFK University Medical Center
Hackensack Meridian Health is proud to announce it is investing $14 million dollars at JFK […]
GeminiBio Appoints Industry Veteran Cory Stevenson as Executive Chairman
Gemini BioProducts (GeminiBio), a portfolio company of BelHealth Investment Partners, a Florida-based healthcare private equity […]
Vanda Pharmaceuticals Appoints Dr. Tage Honoré to its Board of Directors
Vanda Pharmaceuticals today announced the appointment of Dr Tage Honoré, Ph.D., D.Sc. to its Board […]
Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01
Leap Therapeutics, a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that […]
Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology
Invitae, a leading medical genetics company, has announced the appointment of Dr. W. Michael Korn, […]
Synaffix Announces Expansion of ADC Collaboration with MacroGenics
Synaffix, a biotechnology company focused on commercializing its clinical-stage platform technology for the development of […]
Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform
Seamless Therapeutics today announced a $12.5 million (€11.8M) seed financing round which will accelerate further […]
Sage Therapeutics Appoints Jessica Federer to Board of Directors
Sage Therapeutics, a biopharmaceutical company leading the way to create a world with better brain […]
Leucid Bio and Great Ormond Street Hospital Enter Commercial Agreement at New Gene Therapy Manufacturing Centre
Leucid Bio, a biotech company pursuing a differentiated approach to develop next-generation Chimeric Antigen Receptor […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more